What is Rosiglitazone?

Category: Prescription Drugs

Most popular types: Avandia


Rosiglitazone is an antidiabetic agent used for type 2 diabetes to improve glycemic control as an adjunct to diet and exercise. It may be used in combination when diet, exercise and a single agent do not result in adequate control. It is also used for polycystic ovary syndrome.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 1
Mild 0
None 2

Commonly reported side effects and conditions associated with Rosiglitazone

Side effect Patients Percentage
Weight gain 1

Why patients stopped taking Rosiglitazone

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 5
Course of treatment ended 2
Did not seem to work 1
Other 1
Personal research 1
See all 8 patients who've stopped taking Rosiglitazone


Stopped taking Rosiglitazone

Duration Patients Percentage
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 2
2 - 5 years 2
5 - 10 years 2
Adherence Evaluations Percentage
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 3
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 1
$50-99 1
$25-49 0
< $25 0
Not specified 1

What people switch to and from

Patients started taking Rosiglitazone after stopping:

Treatment Patients Percentage
Glimepiride (Amaryl) 1
Glipizide (Glipizide ER) 1

Patients stopped taking Rosiglitazone and switched to:

Treatment Patients Percentage
Exenatide (Bydureon) 1
Glipizide (Glipizide ER) 1
Insulin Glargine (Lantus) 1
Insulin Glulisine (Apidra) 1
Metformin (Metformin ER) 1

Show all 6 treatments patients report switching to

Last updated:
There are no evaluations for Rosiglitazone.